3-(β-萘基)丙酸是一种羧酸类衍生物,用作有机中间体。文献报道,该化合物可以通过以下两种方法制备:首先由2-溴甲基萘经过两步反应得到,或者通过一步还原3-(2-萘基)丙烯酸获得。
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
3-(2-萘基)丙酸甲酯 | methyl 3-(naphthalen-2-yl)propanoate | 81711-55-9 | C14H14O2 | 214.264 |
3-萘-2-基-丙醛 | 3-(naphthalen-2-yl)propanal | 136415-67-3 | C13H12O | 184.238 |
2-萘丙醇 | 3-(2-naphthyl)propan-1-ol | 27650-98-2 | C13H14O | 186.254 |
—— | (2-naphthylmethyl)propanedioic acid | 27650-96-0 | C14H12O4 | 244.247 |
1-(2-萘基)丙-1-酮 | 1-(2-naphthyl)-1-propanone | 6315-96-4 | C13H12O | 184.238 |
—— | 1-chloro-3-(naphthalen-2-yl)propan-2-one | 211031-87-7 | C13H11ClO | 218.683 |
—— | dimethyl (2-naphthylmethyl)malonate | 142077-84-7 | C16H16O4 | 272.301 |
2-(2-溴-乙基)-萘 | 2-(2-bromoethyl)naphthalene | 2086-62-6 | C12H11Br | 235.123 |
—— | diethyl 2-(naphthalen-2-ylmethyl)malonate | 93903-75-4 | C18H20O4 | 300.354 |
—— | N-methoxy-N-methyl-3-(naphthalen-2-yl)propanamide | 197898-79-6 | C15H17NO2 | 243.305 |
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
3-(2-萘基)丙酸甲酯 | methyl 3-(naphthalen-2-yl)propanoate | 81711-55-9 | C14H14O2 | 214.264 |
—— | 2-methyl-3-(naphthalen-2-yl)propanoic acid | 107777-19-5 | C14H14O2 | 214.264 |
3-萘-2-基-丙醛 | 3-(naphthalen-2-yl)propanal | 136415-67-3 | C13H12O | 184.238 |
2-萘丙醇 | 3-(2-naphthyl)propan-1-ol | 27650-98-2 | C13H14O | 186.254 |
—— | 3-(naphthalen-2-yl)propanoyl chloride | 27673-99-0 | C13H11ClO | 218.683 |
—— | 3-(naphthalen-2-yl)-2-(naphthalen-2-ylmethyl)propanoic acid | 188822-05-1 | C24H20O2 | 340.422 |
—— | 2-[2]naphthylmethyl-butyric acid | 165072-19-5 | C15H16O2 | 228.291 |
5-萘-2-基戊酸 | 5-(naphthalen-2-yl)pentanoic acid | 7475-48-1 | C15H16O2 | 228.291 |
—— | 2-(3-bromopropyl)naphthalene | 27650-59-5 | C13H13Br | 249.15 |
—— | 2-cyclopropylnaphthalene | 25033-18-5 | C13H12 | 168.238 |
Prostaglandin E2 (PGE2) is a key mediator of inflammation, and consequently huge efforts have been devoted to the development of novel agents able to regulate its formation. In this work, we present the synthesis of various α-ketoheterocycles and a study of their ability to inhibit the formation of PGE2 at a cellular level. A series of α-ketobenzothiazoles, α-ketobenzoxazoles, α-ketobenzimidazoles, and α-keto-1,2,4-oxadiazoles were synthesized and chemically characterized. Evaluation of their ability to suppress the generation of PGE2 in interleukin-1β plus forskolin-stimulated mesangial cells led to the identification of one α-ketobenzothiazole (GK181) and one α-ketobenzoxazole (GK491), which are able to suppress the PGE2 generation at a nanomolar level.